Peptest News & Industry Updates
Peptest study to feature at Laryngology Conference
Information on a UK multicentre study evaluating the use of Peptest for patients with laryngopharyngeal reflux (LPR) will be presented at a world-class laryngology conference this month.
read more
Peptest gets ‘approval’ to launch in China
Peptest has been officially registered as a product with the Chinese National Medical Products Administration (NMPA) as announced in Beijing this September.
read more
Watch how to use Peptest at home
We are delighted to introduce our new step-by-step video guide to using Peptest saliva test n the comfort of your own home.
read more
Antacids offer instant relief but are often overused
One in four people buy an indigestion relief product every year with antacid sales reported to be worth $10 billion worldwide. Yet antacids should only be use at full therapeutic doses for short periods, a research study has warned.
read more
China study highlights Peptest’s effectiveness
A large-scale, multicentre study that validates the effectiveness of using Peptest to diagnose patients with gastroesophageal reflux in China has been published in the Journal of Digestive Diseases.
read more
An evaluation of the current literature on pepsin
The aim of this paper from Professor Peter Dettmar and his colleagues at Castle Hill Hospital is to link the damaging effects of pepsin on the gastrointestinal tract and how these effects lead to reflux disease.
read more
Extraoesophageal reflux research highlights Peptest
Peptest can be used to diagnose Extraoesophageal reflux (EER) - especially in children with chronic otitis media with effusion (OME) - research highlights.
read more
Myofascial massage and treatment of reflux
Patients with gastroesophageal reflux saw their symptoms improve and the doses of medication that they needed reduced following massage to their diaphragm.
read more
TIF – incisionless treatment for reflux
The Transoral Incisionless Fundoplication (TIF) procedure is an endoscopic treatment for people with refractory gastro-oesophageal reflux disease.
read more
Peptest in new book on foregut diseases
Peptest has been cited in a new book that focusses on the diagnosis and management of specific benign diseases of the foregut, including reflux disease.
read more
Heartburn drugs linked to deadly health issues
New research has linked proton pump inhibitors (PPIs) with fatal cases of cardiovascular disease, chronic kidney disease and upper gastrointestinal cancer.
read more
Peptest demonstrated in tour of South Asia
From Hull to Hanoi - Andrew Woodcock (Woody), RD Biomed’s leading technical expert in Peptest, has completed a successful tour of South Asia presenting the latest information on our non-invasive device for diagnosing reflux.
read more